Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2017	$ 617,092	$ 106,883	$ 534,329	$ (24,120)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(42,679)		(42,679)
Issuance of shares for stock options exercised and restricted stock units vested	4,341	609	3,732
Stock-based compensation expense	5,565		5,565
Contribution of stock to a deferred compensation trust	1,437		1,437
Purchase of common stock	(119,702)	(2,036)	(117,666)
Other comprehensive (loss)/Income	3,380			3,380
Net earnings	153,893		153,893
Balance at end of period at May. 04, 2018	623,327	105,456	538,470	(20,599)
Balance at beginning of period at Feb. 02, 2018	580,781	106,435	490,373	(16,027)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(21,254)		(21,254)
Issuance of shares for stock options exercised and restricted stock units vested	1,342	102	1,240
Stock-based compensation expense	2,441		2,441
Purchase of common stock	(66,559)	(1,081)	(65,478)
Other comprehensive (loss)/Income	(4,713)			(4,713)
Net earnings	131,289		131,289
Balance at end of period at May. 04, 2018	623,327	105,456	538,470	(20,599)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative translation and reclassification adjustment				141
Balance at beginning of period at Oct. 31, 2018	668,916	105,601	587,252	(23,937)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(47,930)		(47,930)
Issuance of shares for stock options exercised and restricted stock units vested	23,004	1,225	21,779
Stock-based compensation expense	7,025		7,025
Contribution of stock to a deferred compensation trust	1,404		1,404
Purchase of common stock	(21,937)	(392)	(21,545)
Other comprehensive (loss)/Income	(1,179)			(1,179)
Net earnings	175,110		175,110
Balance at end of period at May. 03, 2019	805,277	106,434	723,959	(25,116)
Balance at beginning of period at Feb. 01, 2019	694,397	105,747	613,165	(24,515)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(24,007)		(24,007)
Issuance of shares for stock options exercised and restricted stock units vested	16,839	687	16,152
Stock-based compensation expense	3,101		3,101
Purchase of common stock	(22)	0	(22)
Other comprehensive (loss)/Income	(601)			(601)
Net earnings	115,570		115,570
Balance at end of period at May. 03, 2019	$ 805,277	$ 106,434	$ 723,959	$ (25,116)